You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 43 No. 3, March 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (90)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Amyotrophic Lateral Sclerosis

Associated Clinical Disorders and Immunological Evaluations

Stanley H. Appel, MD; Vicki Stockton-Appel, RN; S. Scott Stewart, MD; Ronald H. Kerman, MD

Arch Neurol. 1986;43(3):234-238.


Abstract



• We examined the family history and associated diseases in 58 patients with amyotrophic lateral sclerosis (ALS), as well as the T-cell phenotypes and functions in 46 consecutive patients with this disorder. A family history of thyroid disease was present in 19%, and an additional 21% of patients described family members with other possible autoimmune disorders. In 19% of the patients with ALS either past or present thyroid disease was documented. Eleven of 47 additional patients with ALS had significant elevations of microsomal and/or thyroglobulin antibody levels. The T-cell phenotypes and functions were comparable in the ALS and control groups, with the exception of the presence of Ia antigen. In patients with ALS, 11.9% of the T cells were positive for the Ia antigen, while in both a normal control population and a non-ALS neurologic disease population, only 6.4% of T cells have this antigenic determinant. These data support involvement of autoimmune mechanisms in ALS.



Author Affiliations



From the Department of Neurology, Baylor College of Medicine, Houston (Drs Appel and Stewart and Ms Stockton-Appel); and the Department of Surgery, University of Texas Health Science Center at Houston (Dr Kerman).


Footnotes



Accepted for publication Aug 12, 1985.

Reprint requests to One Baylor Plaza, Houston, TX 77030 (Dr Appel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The epidemiology of ALS in Modena, Italy
Mandrioli et al.
Neurology 2003;60:683-689.
ABSTRACT | FULL TEXT  

Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis
Engelhardt et al.
Arch Neurol 1993;50:30-36.
ABSTRACT  

Antecedent Medical Diseases in Patients With Amyotrophic Lateral Sclerosis: A Population-Based Case-Controlled Study in Rochester, Minn, 1925 Through 1987
Armon et al.
Arch Neurol 1991;48:283-286.
ABSTRACT  

IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis
Engelhardt and Appel
Arch Neurol 1990;47:1210-1216.
ABSTRACT  

A Double-blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis
Appel et al.
Arch Neurol 1988;45:381-386.
ABSTRACT  

Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials
Mitsumoto et al.
Arch Neurol 1988;45:189-202.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.